Auxier Asset Management Sells 398 Shares of CVS Health Co. (NYSE:CVS)

Auxier Asset Management lowered its stake in CVS Health Co. (NYSE:CVS) by 0.4% during the 3rd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 105,256 shares of the pharmacy operator’s stock after selling 398 shares during the period. Auxier Asset Management’s holdings in CVS Health were worth $6,618,000 at the end of the most recent reporting period.

Other hedge funds have also added to or reduced their stakes in the company. Janus Henderson Group PLC grew its stake in CVS Health by 2.5% in the first quarter. Janus Henderson Group PLC now owns 177,372 shares of the pharmacy operator’s stock worth $14,143,000 after purchasing an additional 4,318 shares during the period. Atria Investments Inc increased its stake in shares of CVS Health by 1.3% in the 1st quarter. Atria Investments Inc now owns 97,348 shares of the pharmacy operator’s stock worth $7,764,000 after acquiring an additional 1,292 shares in the last quarter. Cetera Investment Advisers lifted its position in CVS Health by 190.9% during the 1st quarter. Cetera Investment Advisers now owns 407,844 shares of the pharmacy operator’s stock valued at $32,530,000 after acquiring an additional 267,664 shares during the period. Cetera Advisors LLC boosted its stake in CVS Health by 13.3% during the first quarter. Cetera Advisors LLC now owns 123,884 shares of the pharmacy operator’s stock worth $9,881,000 after acquiring an additional 14,551 shares in the last quarter. Finally, EverSource Wealth Advisors LLC grew its holdings in CVS Health by 27.3% in the first quarter. EverSource Wealth Advisors LLC now owns 13,865 shares of the pharmacy operator’s stock worth $1,106,000 after purchasing an additional 2,970 shares during the period. 80.66% of the stock is owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

CVS has been the topic of a number of analyst reports. Truist Financial reissued a “buy” rating and issued a $67.00 price target (down from $76.00) on shares of CVS Health in a research report on Wednesday, November 20th. TD Cowen increased their target price on CVS Health from $73.00 to $80.00 and gave the stock a “buy” rating in a research note on Monday. Evercore ISI lifted their price target on CVS Health from $62.00 to $75.00 and gave the stock an “outperform” rating in a research report on Tuesday, October 8th. UBS Group increased their price objective on shares of CVS Health from $60.00 to $62.00 and gave the company a “neutral” rating in a research report on Thursday, November 7th. Finally, Deutsche Bank Aktiengesellschaft decreased their target price on shares of CVS Health from $64.00 to $63.00 and set a “hold” rating for the company in a report on Friday, August 9th. One research analyst has rated the stock with a sell rating, seven have assigned a hold rating and thirteen have given a buy rating to the stock. According to data from MarketBeat, CVS Health presently has a consensus rating of “Moderate Buy” and an average target price of $70.33.

CVS Health Stock Up 1.6 %

CVS opened at $59.96 on Friday. CVS Health Co. has a 1-year low of $52.71 and a 1-year high of $83.25. The firm’s 50 day simple moving average is $59.33 and its two-hundred day simple moving average is $58.73. The company has a current ratio of 0.80, a quick ratio of 0.59 and a debt-to-equity ratio of 0.80. The company has a market capitalization of $75.45 billion, a PE ratio of 15.22, a PEG ratio of 1.02 and a beta of 0.55.

CVS Health (NYSE:CVS) last released its earnings results on Wednesday, November 6th. The pharmacy operator reported $1.09 earnings per share for the quarter, beating the consensus estimate of $1.08 by $0.01. The company had revenue of $95.43 billion for the quarter, compared to the consensus estimate of $92.72 billion. CVS Health had a return on equity of 10.72% and a net margin of 1.36%. CVS Health’s quarterly revenue was up 6.3% compared to the same quarter last year. During the same period in the previous year, the business earned $2.21 earnings per share. As a group, equities analysts forecast that CVS Health Co. will post 5.37 EPS for the current year.

CVS Health Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Friday, November 1st. Stockholders of record on Monday, October 21st were given a dividend of $0.665 per share. The ex-dividend date was Monday, October 21st. This represents a $2.66 annualized dividend and a dividend yield of 4.44%. CVS Health’s payout ratio is 67.51%.

About CVS Health

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.